Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$7.21 - $14.88 $267,491 - $552,048
37,100 Added 86.08%
80,200 $961,000
Q2 2022

Aug 15, 2022

BUY
$5.97 - $9.97 $137,310 - $229,310
23,000 Added 114.43%
43,100 $361,000
Q4 2021

Feb 14, 2022

BUY
$10.12 - $14.07 $16,191 - $22,512
1,600 Added 8.65%
20,100 $227,000
Q3 2021

Nov 15, 2021

BUY
$7.25 - $13.23 $134,125 - $244,755
18,500 New
18,500 $233,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $90.2M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.